FREQUENCY THERAPEUTICS INC (FREQ) Fundamental Analysis & Valuation

NASDAQ:FREQ • US35803L1089

Current stock price

0.2996 USD
+0.02 (+5.94%)
Last:

This FREQ fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. FREQ Profitability Analysis

1.1 Basic Checks

  • FREQ had negative earnings in the past year.
  • FREQ had a negative operating cash flow in the past year.
FREQ Yearly Net Income VS EBIT VS OCF VS FCFFREQ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 0 20M -20M -40M -60M -80M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -76.59%, FREQ is doing worse than 70.30% of the companies in the same industry.
  • The Return On Equity of FREQ (-145.99%) is worse than 68.48% of its industry peers.
Industry RankSector Rank
ROA -76.59%
ROE -145.99%
ROIC N/A
ROA(3y)-41%
ROA(5y)-34.99%
ROE(3y)-65.47%
ROE(5y)-52.09%
ROIC(3y)N/A
ROIC(5y)N/A
FREQ Yearly ROA, ROE, ROICFREQ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 -20 -40 -60 -80 -100

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for FREQ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FREQ Yearly Profit, Operating, Gross MarginsFREQ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 0 -200 -400 -600

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. FREQ Health Analysis

2.1 Basic Checks

  • FREQ does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • FREQ has more shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, FREQ has a worse debt to assets ratio.
FREQ Yearly Shares OutstandingFREQ Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 10M 20M 30M
FREQ Yearly Total Debt VS Total AssetsFREQ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M 250M

2.2 Solvency

  • FREQ has an Altman-Z score of -5.79. This is a bad value and indicates that FREQ is not financially healthy and even has some risk of bankruptcy.
  • FREQ's Altman-Z score of -5.79 is on the low side compared to the rest of the industry. FREQ is outperformed by 68.98% of its industry peers.
  • FREQ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -5.79
ROIC/WACCN/A
WACC9.02%
FREQ Yearly LT Debt VS Equity VS FCFFREQ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 0 50M -50M 100M 150M

2.3 Liquidity

  • FREQ has a Current Ratio of 3.14. This indicates that FREQ is financially healthy and has no problem in meeting its short term obligations.
  • FREQ has a Current ratio of 3.14. This is in the lower half of the industry: FREQ underperforms 68.48% of its industry peers.
  • FREQ has a Quick Ratio of 3.14. This indicates that FREQ is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of FREQ (3.14) is worse than 67.66% of its industry peers.
Industry RankSector Rank
Current Ratio 3.14
Quick Ratio 3.14
FREQ Yearly Current Assets VS Current LiabilitesFREQ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. FREQ Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 13.39% over the past year.
  • FREQ shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -100.00%.
EPS 1Y (TTM)13.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.91%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 9.00% on average over the next years. This is quite good.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y31.85%
EPS Next 2Y22.39%
EPS Next 3Y13.2%
EPS Next 5Y9%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FREQ Yearly Revenue VS EstimatesFREQ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2028 2029 2030 50M 100M 150M 200M 250M
FREQ Yearly EPS VS EstimatesFREQ Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -0.5 -1 -1.5 -2 -2.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. FREQ Valuation Analysis

4.1 Price/Earnings Ratio

  • FREQ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for FREQ. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FREQ Price Earnings VS Forward Price EarningsFREQ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FREQ Per share dataFREQ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as FREQ's earnings are expected to grow with 13.20% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.39%
EPS Next 3Y13.2%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. FREQ Dividend Analysis

5.1 Amount

  • No dividends for FREQ!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

FREQ Fundamentals: All Metrics, Ratios and Statistics

FREQUENCY THERAPEUTICS INC

NASDAQ:FREQ (11/3/2023, 8:00:00 PM)

0.2996

+0.02 (+5.94%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Industry Strength55.9
Industry Growth13.04
Earnings (Last)11-02
Earnings (Next)03-08
Inst Owners0%
Inst Owner Change0%
Ins Owners6.57%
Ins Owner Change0%
Market Cap11.06M
Revenue(TTM)N/A
Net Income(TTM)-77.74M
Analysts43.33
Price Target0.51 (70.23%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.2%
Min EPS beat(2)-28.23%
Max EPS beat(2)23.84%
EPS beat(4)3
Avg EPS beat(4)3.01%
Min EPS beat(4)-28.23%
Max EPS beat(4)23.84%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-87.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-2.99%
EPS NY rev (3m)3.56%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.21
P/tB 0.21
EV/EBITDA N/A
EPS(TTM)-2.2
EYN/A
EPS(NY)-1.16
Fwd EYN/A
FCF(TTM)-1.49
FCFYN/A
OCF(TTM)-1.49
OCFYN/A
SpS0
BVpS1.44
TBVpS1.44
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -76.59%
ROE -145.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-41%
ROA(5y)-34.99%
ROE(3y)-65.47%
ROE(5y)-52.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2.89%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.14
Quick Ratio 3.14
Altman-Z -5.79
F-Score2
WACC9.02%
ROIC/WACCN/A
Cap/Depr(3y)228.34%
Cap/Depr(5y)176.71%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.91%
EPS Next Y31.85%
EPS Next 2Y22.39%
EPS Next 3Y13.2%
EPS Next 5Y9%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y7.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year14.45%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y19.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y10.23%
OCF growth 3YN/A
OCF growth 5YN/A

FREQUENCY THERAPEUTICS INC / FREQ Fundamental Analysis FAQ

What is the ChartMill fundamental rating of FREQUENCY THERAPEUTICS INC (FREQ) stock?

ChartMill assigns a fundamental rating of 2 / 10 to FREQ.


What is the valuation status for FREQ stock?

ChartMill assigns a valuation rating of 0 / 10 to FREQUENCY THERAPEUTICS INC (FREQ). This can be considered as Overvalued.


Can you provide the profitability details for FREQUENCY THERAPEUTICS INC?

FREQUENCY THERAPEUTICS INC (FREQ) has a profitability rating of 0 / 10.


Can you provide the financial health for FREQ stock?

The financial health rating of FREQUENCY THERAPEUTICS INC (FREQ) is 5 / 10.